AFP and hepatocellular carcinoma: Notably, it still maintains effective diagnosis in HCC patients who were negative for AFP (<20 ng/mL), PIVKA-II (<40 mAU/mL) and even negative for both AFP and PIVKA-II (Supplementary Fig. 4b-d).